INTRODUCTION: Four benzamide analogs having a high affinity and selectivity for D(3) versus D(2) receptors were radiolabeled with (11)C or (18)F for in vivo evaluation. METHODS: Precursors were synthesized, and the four D(3) selective benzamide analogs were radiolabeled. The tissue distribution and brain uptake of the four compounds were evaluated in control rats and rats pretreated with cyclosporin A, a modulator of P-glycoprotein and an inhibitor of other ABC efflux transporters that contribute to the blood brain barrier. Micro-positron emission tomographic (PET) imaging was carried out for [(11)C]6 in a control and a cyclosporin A pretreated rat. RESULTS: All four compounds showed low brain uptake in control rats at 5 and 30 min post-injection; despite recently reported rat behavioral studies conducted on analogs 6 (WC-10) and 7 (WC-44). Following administration of cyclosporin A, increased brain uptake was observed with all four PET radiotracers at both 5 and 30 min post-intravenous injection. An increase in brain uptake following modulation/inhibition of the ABC transporters was also observed in the microPET study. CONCLUSIONS: These data suggest that D3 selective conformationally-flexible benzamide analogs which contain a N-2-methoxyphenylpiperazine moiety are substrates for P-glycoprotein or other adenosine triphosphate (ATP)-binding cassette transporters expressed at the blood-brain barrier, and that PET radiotracers containing this pharmacophore may display low brain uptake in rodents due to the action of these efflux transporters.
INTRODUCTION: Four benzamide analogs having a high affinity and selectivity for D(3) versus D(2) receptors were radiolabeled with (11)C or (18)F for in vivo evaluation. METHODS: Precursors were synthesized, and the four D(3) selective benzamide analogs were radiolabeled. The tissue distribution and brain uptake of the four compounds were evaluated in control rats and rats pretreated with cyclosporin A, a modulator of P-glycoprotein and an inhibitor of other ABC efflux transporters that contribute to the blood brain barrier. Micro-positron emission tomographic (PET) imaging was carried out for [(11)C]6 in a control and a cyclosporin A pretreated rat. RESULTS: All four compounds showed low brain uptake in control rats at 5 and 30 min post-injection; despite recently reported rat behavioral studies conducted on analogs 6 (WC-10) and 7 (WC-44). Following administration of cyclosporin A, increased brain uptake was observed with all four PET radiotracers at both 5 and 30 min post-intravenous injection. An increase in brain uptake following modulation/inhibition of the ABC transporters was also observed in the microPET study. CONCLUSIONS: These data suggest that D3 selective conformationally-flexible benzamide analogs which contain a N-2-methoxyphenylpiperazine moiety are substrates for P-glycoprotein or other adenosine triphosphate (ATP)-binding cassette transporters expressed at the blood-brain barrier, and that PET radiotracers containing this pharmacophore may display low brain uptake in rodents due to the action of these efflux transporters.
Authors: Jeih-San Liow; Shuiyu Lu; Julie A McCarron; Jinsoo Hong; John L Musachio; Victor W Pike; Robert B Innis; Sami S Zoghbi Journal: Synapse Date: 2007-02 Impact factor: 2.562
Authors: C Guigoni; I Aubert; Q Li; V V Gurevich; J L Benovic; S Ferry; U Mach; H Stark; L Leriche; K Håkansson; Bernard H Bioulac; Christian E Gross; Pierre Sokoloff; Gilberto Fisone; E V Gurevich; Bertrand Bloch; Erwan Bezard Journal: Parkinsonism Relat Disord Date: 2005-06 Impact factor: 4.891
Authors: Rakesh Kumar; Lindsay R Riddle; Suzy A Griffin; Wenhua Chu; Suwanna Vangveravong; Janet Neisewander; Robert H Mach; Robert R Luedtke Journal: Neuropharmacology Date: 2009-02-05 Impact factor: 5.250
Authors: C Reavill; S G Taylor; M D Wood; T Ashmeade; N E Austin; K Y Avenell; I Boyfield; C L Branch; J Cilia; M C Coldwell; M S Hadley; A J Hunter; P Jeffrey; F Jewitt; C N Johnson; D N Jones; A D Medhurst; D N Middlemiss; D J Nash; G J Riley; C Routledge; G Stemp; K M Thewlis; B Trail; A K Vong; J J Hagan Journal: J Pharmacol Exp Ther Date: 2000-09 Impact factor: 4.030
Authors: Junfeng Li; Xiang Zhang; Zhanbin Zhang; Prashanth K Padakanti; Hongjun Jin; Jinquan Cui; Aixiao Li; Dexing Zeng; Nigam P Rath; Hubert Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu Journal: J Med Chem Date: 2013-07-18 Impact factor: 7.446
Authors: Richard Laforest; Morvarid Karimi; Stephen M Moerlein; Jinbin Xu; Hubert P Flores; Christopher Bognar; Aixiao Li; Robert H Mach; Joel S Perlmutter; Zhude Tu Journal: Am J Nucl Med Mol Imaging Date: 2016-11-30
Authors: Claudia Rangel-Barajas; Maninder Malik; Michelle Taylor; Kim A Neve; Robert H Mach; Robert R Luedtke Journal: J Neurochem Date: 2014-08-19 Impact factor: 5.372